Clinical Trial Update: ATRA and Carfilzomib in Plasma Cell Myeloma Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating the combination of all-trans retinoic acid (ATRA) and carfilzomib in patients with multiple my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• TRETINOIN (TRETINOIN)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING